02196 FOSUN PHARMA
- 12.260
- +0.260+2.17%
FOSUN PHARMA News
FOSUN PHARMA: POLL RESULTS OF THE RESOLUTION PROPOSED AT THE 2023 FIRST EXTRAORDINARY GENERAL MEETING HELD ON FRIDAY, 13 OCTOBER 2023
FOSUN PHARMA: NOTICE OF 2023 FIRST EXTRAORDINARY GENERAL MEETING
FOSUN PHARMA: NOTICE OF 2023 FIRST H SHAREHOLDERS CLASS MEETING
FOSUN PHARMA: NOTICE OF ANNUAL GENERAL MEETING
FOSUN PHARMA: POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2022 SECOND EXTRAORDINARY GENERAL MEETING, THE 2022 SECOND A SHAREHOLDERS CLASS MEETING AND THE 2022 SECOND H SHAREHOLDERS CLASS MEETING HELD ON TUESDAY, 29 NOVEMBER 2022
FOSUN PHARMA: SECOND SUPPLEMENTAL ANNOUNCEMENT TO THE CIRCULAR OF THE COMPANY DATED 31 OCTOBER 2022
FOSUN PHARMA: SUPPLEMENTAL ANNOUNCEMENT TO THE CIRCULAR OF THE COMPANY DATED 31 OCTOBER 2022
FOSUN PHARMA: NOTICE OF 2022 SECOND H SHAREHOLDERS CLASS MEETING
FOSUN PHARMA: NOTICE OF 2022 SECOND EXTRAORDINARY GENERAL MEETING
FOSUN PHARMA: POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2022 FIRST EXTRAORDINARY GENERAL MEETING HELD ON WEDNESDAY, 10 AUGUST 2022 AND ELECTION OF EXECUTIVE DIRECTOR
FOSUN PHARMA: NOTICE OF THE 2022 FIRST EXTRAORDINARY GENERAL MEETING
FOSUN PHARMA: PROVISION OF LOAN TO FOSUN KITE (A JOINT VENTURE) IN PROPORTION TO EQUITY INTEREST; PROVISION OF GUARANTEE IN RESPECT OF FUSHANG YUANCHUANG (AN INVESTEE COMPANY) IN PROPORTION TO EQUITY INTEREST; AMENDMENTS TO THE ARTICLES OF ASSOCIATION; AME
FOSUN PHARMA: CHANGE ON THE CONVENING METHOD OF THE ANNUAL GENERAL MEETING AND 2022 FIRST H SHAREHOLDERS CLASS MEETING
FOSUN PHARMA: NOTICE OF 2022 FIRST H SHAREHOLDERS CLASS MEETING
FOSUN PHARMA: NOTICE OF ANNUAL GENERAL MEETING
FOSUN PHARMA: ANNUAL GENERAL MEETING; PROPOSED ISSUANCE OF CORPORATE BONDS; PROPOSED ADOPTION OF THE SHARE OPTION SCHEME OF FOSUN HEALTH; RENEWED AND ADDITIONAL GUARANTEE QUOTA; GRANT OF GENERAL MANDATE TO ISSUE A SHARES AND/OR H SHARES; GRANT OF GENERAL M
FOSUN PHARMA: (1) PROPOSED APPOINTMENT OF MEMBERS OF THE NINTH SESSION OF THE BOARD AND (2) PROPOSED APPOINTMENT OF MEMBERS OF THE NINTH SESSION OF THE SUPERVISORY COMMITTEE
FOSUN PHARMA: POLL RESULTS OF THE RESOLUTIONS PROPOSED AT THE 2021 THIRD EXTRAORDINARY GENERAL MEETING HELD ON TUESDAY, 7 DECEMBER 2021 AND ELECTION OF EXECUTIVE DIRECTORS
FOSUN PHARMA: NOTICE OF THE 2021 THIRD EXTRAORDINARY GENERAL MEETING
FOSUN PHARMA: (1) EXTENSION OF AUTHORISATION PERIOD AND CHANGE OF AUTHORISED PERSON FOR THE PROPOSED SHANGHAI HENLIUS LISTING (2) ELECTION OF EXECUTIVE DIRECTORS AND NOTICE OF EGM
Analysis
Price Target
No Data
